Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

COVID-19

Free Subscription Articles published in Travel Med Infect Dis Retrieve available abstracts of 102 articles: HTML format

Single Articles

November 2025
1. HEDRICH N, Lovey T, Bernhard J, Grobusch MP, et al
   Real-time illness monitoring in travellers: an international, prospective, digital surveillance study.
   Travel Med Infect Dis. 2025;68:102943.
   PubMed     Abstract available
   
   
   
2. LEI Z, Lei Z, Wang Q
   Temporal and spatial dynamics of dengue fever in mainland China from 2004 to 2020 and the impact of COVID-19 public health interventions.
   Travel Med Infect Dis. 2025;68:102938.
   PubMed     Abstract available
   
   
   
3. CHAO HY, Chang CJ, Lai TJ, Tsai JS, et al
   Loneliness in Long-term Taiwanese Expatriates and Domestic Residents in the COVID-19 Era: A Cross-sectional Study.
   Travel Med Infect Dis. 2025 Nov 5:102928. doi: 10.1016/j.tmaid.2025.102928.
   PubMed     Abstract available
   
   
   August 2025
4. NEUMANN JA, Zimmermann J, Frese M, Dirksen-Fischer M, et al
   Infectious diseases on passenger ships: Port preparedness and response - A narrative systematic review.
   Travel Med Infect Dis. 2025;67:102886.
   PubMed     Abstract available
   
   
   April 2025
5. FERRIS LJ, Kang J, Rathbone JA, Cruwys T, et al
   Vaccine uptake and adherence to non-pharmaceutical interventions at a youth mass gathering event: A longitudinal field cohort study.
   Travel Med Infect Dis. 2025 Apr 13:102853. doi: 10.1016/j.tmaid.2025.102853.
   PubMed     Abstract available
   
   
   March 2025
6. PFAAR H, Lopez-Medina E, Escudero I, Hutagalung Y, et al
   Operational challenges and lessons learned from conducting febrile surveillance in a long-term randomized dengue vaccine trial in Latin America and Asia-Pacific.
   Travel Med Infect Dis. 2025 Mar 20:102840. doi: 10.1016/j.tmaid.2025.102840.
   PubMed     Abstract available
   
   
   
7. BOGACKA A, Wroczynska A, Grzybek M
   Polish travellers on the move: a study of knowledge of travel health and associated practices among Polish travellers abroad.
   Travel Med Infect Dis. 2025 Mar 20:102842. doi: 10.1016/j.tmaid.2025.102842.
   PubMed     Abstract available
   
   
   
8. RODRIGUEZ-MORALES AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, et al
   Infectious Diseases Prevention and Vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien Gap, Panama.
   Travel Med Infect Dis. 2025 Mar 18:102839. doi: 10.1016/j.tmaid.2025.102839.
   PubMed    
   
   
   
9. SRIVASTAVA S, Sharma D, Sridhar SB, Kumar S, et al
   HKU5-CoV-2: A silent threat looming in bats.
   Travel Med Infect Dis. 2025;65:102838.
   PubMed    
   
   
   February 2025
10. SAHIN OE, Kalay Z, Sari ND, Batirel A, et al
    Malaria in Turkey: A comprehensive analysis of diagnosis, treatment, and the impact of COVID-19, ten years after malaria elimination (2012-2023).
    Travel Med Infect Dis. 2025;64:102819.
    PubMed     Abstract available
    
    
    
11. FLOREZ L, Echeverri-De la Hoz D, Calderon A, Serrano-Coll H, et al
    Preclinical evaluation of the RBD-Trimeric vaccine: A novel approach to strengthening biotechnological sovereignty in developing countries against SARS-CoV-2 variants.
    Travel Med Infect Dis. 2025;64:102820.
    PubMed     Abstract available
    
    
    January 2025
12. PLAZA PI, Lambertucci SA
    Differences between Influenza H5N1, A/H1N1 2009, and SARS-CoV-2 in a pandemic risk scenario.
    Travel Med Infect Dis. 2025 Jan 31:102811. doi: 10.1016/j.tmaid.2025.102811.
    PubMed    
    
    
    
13. ALBY A, Power A, Flaherty GT
    Analysis of consular assistance provided to Irish citizens abroad, 2014-2023.
    Travel Med Infect Dis. 2025 Jan 20:102803. doi: 10.1016/j.tmaid.2025.102803.
    PubMed     Abstract available
    
    
    
14. FAGONI N, Stirparo G, Sechi GM, Comelli A, et al
    The leading "blended" civil medical evacuation operation (MEDEVAC) in unforeseen health emergency. From military use to civil development.
    Travel Med Infect Dis. 2025;63:102794.
    PubMed     Abstract available
    
    
    November 2024
15. KHAN AA, Balkhi BS, Alamri FA, Alsaleh GS, et al
    Vaccinations for Hajj: Enhancing health and global health security.
    Travel Med Infect Dis. 2024;63:102784.
    PubMed     Abstract available
    
    
    
16. OPE M, Musyoka R, Kosar A, Osman M, et al
    Epidemiology and response to the COVID-19 pandemic in the Dadaab Refugee Camp Complex, March 2020- December 2022.
    Travel Med Infect Dis. 2024 Nov 19:102785. doi: 10.1016/j.tmaid.2024.102785.
    PubMed     Abstract available
    
    
    
17. WANG J, Ge L, Zhou K, Jiang Y, et al
    Effect of omicron infection on maternal and neonatal delivery outcomes: A retrospective cohort study.
    Travel Med Infect Dis. 2024;62:102759.
    PubMed     Abstract available
    
    
    October 2024
18. OLIVEIRA-FILHO EF, Vega RM, Moreira-Soto A, Beuchel C, et al
    Post-migration infection with SARS-CoV-2 in Venezuelan migrants: a laboratory-based epidemiological observational study.
    Travel Med Infect Dis. 2024 Oct 16:102772. doi: 10.1016/j.tmaid.2024.102772.
    PubMed     Abstract available
    
    
    July 2024
19. FERREIRA AM, de Oliveira-da Silva LC, Cardoso CS, Oliveira CDL, et al
    Association between positive serology for COVID-19 and Chagas cardiomyopathy progression: The SaMi-Trop Project.
    Travel Med Infect Dis. 2024 Jul 22:102745. doi: 10.1016/j.tmaid.2024.102745.
    PubMed     Abstract available
    
    
    June 2024
20. PETAKH P, Tymchyk V, Kamyshnyi O
    Communicable diseases in Ukraine during the period of 2018-2023: Impact of the COVID-19 pandemic and war.
    Travel Med Infect Dis. 2024 Jun 26:102733. doi: 10.1016/j.tmaid.2024.102733.
    PubMed     Abstract available
    
    
    
21. KOISO S, Gulbas E, Dike L, Mulroy NM, et al
    Modeling approaches to inform travel-related policies for COVID-19 containment: a scoping review and future directions.
    Travel Med Infect Dis. 2024 Jun 1:102730. doi: 10.1016/j.tmaid.2024.102730.
    PubMed     Abstract available
    
    
    February 2024
22. GAGLIARDINI R, Giacomelli A, Bozzi G, D'Arminio Monforte A, et al
    Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort.
    Travel Med Infect Dis. 2024;58:102691.
    PubMed     Abstract available
    
    
    December 2023
23. SALMANTON-GARCIA J, Wipfler P, Leckler J, Naucler P, et al
    Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics.
    Travel Med Infect Dis. 2023 Dec 5:102676. doi: 10.1016/j.tmaid.2023.102676.
    PubMed     Abstract available
    
    
    November 2023
24. RAMASAUSKAITE RAMASAUSKAITE D, Grinciute Grinciute D
    Review of short-term and long-term adverse effects of covid-19 vaccination during pregnancy.
    Travel Med Infect Dis. 2023 Nov 9:102667. doi: 10.1016/j.tmaid.2023.102667.
    PubMed     Abstract available
    
    
    
25. MUNOZ-DEL-CARPIO-TOIA A, Bartolo-Marchena M, Benites-Zapata VA, Herrera-Anazco P, et al
    Mortality from COVID-19 in Amazonian and Andean original indigenous populations of Peru.
    Travel Med Infect Dis. 2023 Nov 7:102658. doi: 10.1016/j.tmaid.2023.102658.
    PubMed     Abstract available
    
    
    October 2023
26. LIU S, Shen X, Zhang F, Shi X, et al
    Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study.
    Travel Med Infect Dis. 2023 Oct 26:102656. doi: 10.1016/j.tmaid.2023.102656.
    PubMed    
    
    
    
27. VALDERRAMA-BELTRAN S, Cuervo-Rojas J, Martinez-Vernaza S, Alvarez-Moreno CA, et al
    SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?
    Travel Med Infect Dis. 2023 Oct 7:102650. doi: 10.1016/j.tmaid.2023.102650.
    PubMed     Abstract available
    
    
    August 2023
28. SINGH SB, Padhi BK, Gandhi AP, Lohani P, et al
    Burden of stillbirths among women vaccinated with COVID-19 vaccines: A systematic review and meta-analysis.
    Travel Med Infect Dis. 2023 Aug 19:102633. doi: 10.1016/j.tmaid.2023.102633.
    PubMed     Abstract available
    
    
    July 2023
29. PALAMIM CVC, Siqueira BA, Boschiero MN, Marson FAL, et al
    Increase in COVID-19 underreporting among 3,282,337 Brazilian hospitalized patients due to SARS: A 3-year report and a major concern for health authorities.
    Travel Med Infect Dis. 2023 Jul 11:102616. doi: 10.1016/j.tmaid.2023.102616.
    PubMed    
    
    
    June 2023
30. GARCIA-MARIN NM, Marrero GA, Guerra Neira A, Rivera Dean A, et al
    Profiles of travelers to intermediate-high health risk areas following the reopening of borders in the COVID-19 crisis: A clustering approach.
    Travel Med Infect Dis. 2023;54:102607.
    PubMed     Abstract available
    
    
    
31. GULISANO LM, Ianiro Swiderski JJ, Fernandez ML, Giuliano JF, et al
    Acute colonic pseudo-obstruction syndrome in patients with severe COVID-19 in Buenos Aires, Argentina.
    Travel Med Infect Dis. 2023 Jun 12:102604. doi: 10.1016/j.tmaid.2023.102604.
    PubMed     Abstract available
    
    
    
32. RODRIGUEZ-MORALES AJ, Lopez-Echeverri MC, Perez-Raga MF, Quintero-Romero V, et al
    The global challenges of the long COVID-19 in adults and children.
    Travel Med Infect Dis. 2023 Jun 7:102606. doi: 10.1016/j.tmaid.2023.102606.
    PubMed    
    
    
    May 2023
33. GAUTRET P
    Decline in rabies cases in international travelers during the COVID-19 pandemic.
    Travel Med Infect Dis. 2023;54:102592.
    PubMed    
    
    
    
34. GROBUSCH MP, Weld L, Schnyder JL, Larsen CS, et al
    COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe.
    Travel Med Infect Dis. 2023 May 17:102583. doi: 10.1016/j.tmaid.2023.102583.
    PubMed     Abstract available
    
    
    
35. ALVAREZ-MORENO C, Valderrama-Beltran SL, Silva R, De La Hoz Siegler IH, et al
    Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
    Travel Med Infect Dis. 2023 May 9:102579. doi: 10.1016/j.tmaid.2023.102579.
    PubMed     Abstract available
    
    
    April 2023
36. AFTAB H, Kemp M, Stensvold CR, Nielsen HV, et al
    First molecular documented case of a rarely reported parasite: Plasmodium knowlesi infection in Denmark in a traveller returning from Malaysian Borneo.
    Travel Med Infect Dis. 2023;53:102580.
    PubMed     Abstract available
    
    
    
37. SHOMUYIWA DO, Manirambona E
    Monkeypox virus declared as a global health emergency: What next for Africa's preparedness?
    Travel Med Infect Dis. 2023;53:102577.
    PubMed     Abstract available
    
    
    March 2023
38. SILVA-VALENCIA J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, et al
    Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021.
    Travel Med Infect Dis. 2023;53:102565.
    PubMed     Abstract available
    
    
    
39. AL-KASSAB-CORDOVA A, Silva-Perez C, Mendez-Guerra C, Herrera-Anazco P, et al
    Factors associated with not receiving the primary series and booster dose of the COVID-19 vaccine among Venezuelan migrants in Peru: A population-based cross-sectional study.
    Travel Med Infect Dis. 2023;53:102563.
    PubMed     Abstract available
    
    
    
40. SAH R, Mohapatra RK, Mishra S, Chinnam S, et al
    Cocktail of FIFA 2022 Vis-A-Vis camel beauty pageant championship; potential health threat of MERS among players and fans - A possible global spread.
    Travel Med Infect Dis. 2023;52:102541.
    PubMed    
    
    
    February 2023
41. WU Y, Feng Y, Wan J, Du W, et al
    Cycle threshold values are not associated with mortality: Risk factor analysis in older patients with the SARS-CoV-2 Omicron variant.
    Travel Med Infect Dis. 2023 Feb 20:102555. doi: 10.1016/j.tmaid.2023.102555.
    PubMed    
    
    
    
42. DAM P, Cardoso MH, Mandal S, Franco OL, et al
    Surge of mucormycosis during the COVID-19 pandemic.
    Travel Med Infect Dis. 2023;52:102557.
    PubMed     Abstract available
    
    
    
43. LI Z, Yang B, Wang J, Wen Y, et al
    Global border restrictions in 2020-2021: Adherence and the effectiveness in long-term COVID-19 epidemic control.
    Travel Med Infect Dis. 2023;52:102556.
    PubMed     Abstract available
    
    
    
44. FERNANDEZ-ORTEGA MA, Ponce-Rosas ER, Muniz-Salinas DA, Rodriguez-Mendoza O, et al
    Cognitive dysfunction, diabetes mellitus 2 and arterial hypertension: Sequelae up to one year of COVID-19.
    Travel Med Infect Dis. 2023 Feb 15:102553. doi: 10.1016/j.tmaid.2023.102553.
    PubMed     Abstract available
    
    
    
45. XIE JW, Zheng YW, Wang M, Lin Y, et al
    Nasal swab is a good alternative sample for detecting SARS-CoV-2 with rapid antigen test: A meta-analysis.
    Travel Med Infect Dis. 2023;52:102548.
    PubMed     Abstract available
    
    
    January 2023
46. SHAPO L, Puca E
    What could drive the re-emergence of infectious diseases in a post-Covid19 era?
    Travel Med Infect Dis. 2023 Jan 27:102546. doi: 10.1016/j.tmaid.2023.102546.
    PubMed    
    
    
    December 2022
47. SHAFAATI M, Zandi M, Priyanka, Choudhary OP, et al
    Impact of epigenetic mechanisms in re-emerging viruses.
    Travel Med Infect Dis. 2022;52:102535.
    PubMed    
    
    
    
48. WOOLLEY SD, Dermont M, Adam M, Pallet SJC, et al
    The 2022 monkeypox outbreak: A UK military perspective.
    Travel Med Infect Dis. 2022;52:102540.
    PubMed     Abstract available
    
    
    
49. ZHANG Y, Guo X, Han S, Yao M, et al
    Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination.
    Travel Med Infect Dis. 2022 Dec 19:102531. doi: 10.1016/j.tmaid.2022.102531.
    PubMed    
    
    
    
50. SOHAIL A, Akritidis J, McGuinness S, Leder K, et al
    Perceptions of travel-related health risks and pre-travel health-seeking behaviour among students: A qualitative analysis.
    Travel Med Infect Dis. 2022;52:102532.
    PubMed     Abstract available
    
    
    November 2022
51. CVETKOVIC-VEGA A, Urrunaga-Pastor D, Soto-Becerra P, Figueroa Morales LE, et al
    Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm).
    Travel Med Infect Dis. 2022 Nov 30:102514. doi: 10.1016/j.tmaid.2022.102514.
    PubMed     Abstract available
    
    
    
52. BARBOSA VINASCO HJ, Rojas Herrera D, Fernandez Gomez LM, Osorio Delgado LA, et al
    Epidemiological characterization of the pediatric population diagnosed for SARS-CoV-2 in the public health laboratory from Tolima, Colombia: A retrospective analysis 2020-2022.
    Travel Med Infect Dis. 2022;51:102507.
    PubMed    
    
    
    
53. ALVAREZ-MORENO CA, Pineda J, Bareno A, Espitia R, et al
    Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?
    Travel Med Infect Dis. 2022;51:102492.
    PubMed    
    
    
    
54. TURCATO G, Zaboli A, Giudiceandrea A, Sibilio S, et al
    Impact of tourists on emergency department in a high-tourism alpin area: An observational study.
    Travel Med Infect Dis. 2022 Nov 5:102491. doi: 10.1016/j.tmaid.2022.102491.
    PubMed     Abstract available
    
    
    October 2022
55. AKRITIDIS J, McGuinness SL, Leder K
    University students' travel risk perceptions and risk-taking willingness during the COVID-19 pandemic: A cross-sectional study.
    Travel Med Infect Dis. 2022;51:102486.
    PubMed     Abstract available
    
    
    
56. MERCIER A, Meheut A, Alidjinou EK, Lazrek M, et al
    Respiratory virus detection in returning travelers and pilgrims from the Middle East.
    Travel Med Infect Dis. 2022 Oct 21:102482. doi: 10.1016/j.tmaid.2022.102482.
    PubMed     Abstract available
    
    
    
57. CAIRA-CHUQUINEYRA B, Fernandez-Guzman D, Alvarez-Arias PM, Zarate-Curi AA, et al
    Association between prehospital medication and fatal outcomes in a cohort of hospitalized patients due to coronavirus disease-2019 in a referral hospital in Peru.
    Travel Med Infect Dis. 2022;50:102472.
    PubMed     Abstract available
    
    
    September 2022
58. DEL CARPIO-ORANTES L, Mejia-Ramos SG, Aguilar-Silva A
    COVID-19 and dengue coinfection in Veracruz, Mexico.
    Travel Med Infect Dis. 2022 Sep 27:102467. doi: 10.1016/j.tmaid.2022.102467.
    PubMed    
    
    
    
59. FORERO-PENA DA, Carrion-Nessi FS, Omana-Avila OD, Mendoza-Millan DL, et al
    Plasmodium vivax and SARS-CoV-2 co-infection in Venezuela: A case series from the malaria hotspot in Latin America.
    Travel Med Infect Dis. 2022;50:102460.
    PubMed    
    
    
    
60. MERENESS RA, Trent S, Cummins J, Olson N, et al
    Comments on "Identifying mitigation strategies for COVID-19 superspreading on flights using models that account for passenger movement".
    Travel Med Infect Dis. 2022 Sep 13:102452. doi: 10.1016/j.tmaid.2022.102452.
    PubMed    
    
    
    
61. NAMILAE S, Wu Y, Mubayi A, Srinivasan A, et al
    Reply to comments on "Identifying mitigation strategies for COVID-19 superspreading on flights using models that account for passenger movement".
    Travel Med Infect Dis. 2022 Sep 13:102453. doi: 10.1016/j.tmaid.2022.102453.
    PubMed    
    
    
    
62. SAH R, Alshahrani NZ, Shah P, Mohanty A, et al
    FIFA World Cup 2022 in Qatar: Mitigating the risk of imported infections amid the COVID-19 pandemic, monkeypox outbreak and other emerging diseases.
    Travel Med Infect Dis. 2022;50:102450.
    PubMed    
    
    
    
63. HEMATI S, Farhadkhani M, Sanami S, Mohammadi-Moghadam F, et al
    A review on insights and lessons from COVID-19 to the prevent of monkeypox pandemic.
    Travel Med Infect Dis. 2022;50:102441.
    PubMed     Abstract available
    
    
    
64. CHU DT, Thi HV, Al-Tawfiq JA, Memish ZA, et al
    Children orphaned by COVID-19: A grim picture and the need of urgent actions.
    Travel Med Infect Dis. 2022 Sep 2:102446. doi: 10.1016/j.tmaid.2022.102446.
    PubMed     Abstract available
    
    
    August 2022
65. SABANER E, Kolbakir F, Ercan E
    Evaluation of fatigue and sleep problems in cabin crews during the early COVID-19 pandemic period.
    Travel Med Infect Dis. 2022 Aug 24:102430. doi: 10.1016/j.tmaid.2022.102430.
    PubMed     Abstract available
    
    
    
66. SAIAG E, Marudi O, Cohen N, Goldiner I, et al
    Anti-SARS-CoV-2 antibody levels after four BNT162b2 vaccine doses among health-care workers.
    Travel Med Infect Dis. 2022 Aug 17:102429. doi: 10.1016/j.tmaid.2022.102429.
    PubMed    
    
    
    
67. TEMSAH MH, Aljamaan F, Alenezi S, Alhasan K, et al
    Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: Experience from Saudi Arabia.
    Travel Med Infect Dis. 2022;49:102426.
    PubMed     Abstract available
    
    
    
68. DIAZ A, Serrano-Coll H, Botero Y, Calderon A, et al
    Immunogenicity and safety of a RBD vaccine against SARS-CoV-2 in a murine model.
    Travel Med Infect Dis. 2022;49:102427.
    PubMed     Abstract available
    
    
    
69. URRUNAGA-PASTOR D, Fernandez-Guzman D, Caira-Chuquineyra B, Herrera-Anazco P, et al
    Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean.
    Travel Med Infect Dis. 2022 Aug 9:102409. doi: 10.1016/j.tmaid.2022.102409.
    PubMed     Abstract available
    
    
    
70. REDA A, Sah R, Abdelaal A, Shrestha S, et al
    The emergence of cholera in multiple countries amidst current COVID-19 pandemic: Situation and implications for public health and travel medicine.
    Travel Med Infect Dis. 2022 Aug 8:102423. doi: 10.1016/j.tmaid.2022.102423.
    PubMed    
    
    
    
71. AL-TAWFIQ JA, Memish ZA
    COVID-19 isolation strategies: What have we learned.
    Travel Med Infect Dis. 2022 Aug 8:102416. doi: 10.1016/j.tmaid.2022.102416.
    PubMed     Abstract available
    
    
    
72. EL-ARABEY AA, Abdalla M
    Cardiovascular complications in the post-acute COVID-19 syndrome: A novel perspective down the road.
    Travel Med Infect Dis. 2022;49:102421.
    PubMed    
    
    
    
73. GOUMBALLA N, Hoang VT, Diouf FS, Mbaye B, et al
    Risk factors for symptoms of infection and the acquisition of pathogens among pilgrims at the Grand Magal of Touba, 2017-2021.
    Travel Med Infect Dis. 2022;49:102418.
    PubMed     Abstract available
    
    
    
74. SHAFAATI M, Zandi M
    Monkeypox virus neurological manifestations in comparison to other orthopoxviruses.
    Travel Med Infect Dis. 2022 Aug 1:102414. doi: 10.1016/j.tmaid.2022.102414.
    PubMed     Abstract available
    
    
    July 2022
75. LI C, Zhu X, Zhang Y, Zhang J, et al
    COVID-19 influences both physical and mental health: Lessons from bibliometric analysis.
    Travel Med Infect Dis. 2022 Jul 30:102405. doi: 10.1016/j.tmaid.2022.102405.
    PubMed    
    
    
    
76. LUNA N, Ramirez AL, Munoz M, Ballesteros N, et al
    Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage?
    Travel Med Infect Dis. 2022;49:102402.
    PubMed     Abstract available
    
    
    
77. KARACIC J, Zanetti M, Marusic A
    How difficult it was to acquire COVID digital certificate in summer 2021: Response of EU national contact points for cross-border health care.
    Travel Med Infect Dis. 2022;48:102347.
    PubMed    
    
    
    June 2022
78. BHATTACHARYA M, Dhama K, Chakraborty C
    Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective.
    Travel Med Infect Dis. 2022;49:102398.
    PubMed     Abstract available
    
    
    
79. SOARES DA SILVA M, Gularte JS, Demoliner M, Hansen AW, et al
    Brief dispersion of a putative B.1.1.28-derived SARS-CoV-2 lineage harboring additional N234P and E471Q spike protein mutations in individuals crossing the Argentina-Brazil border.
    Travel Med Infect Dis. 2022;49:102390.
    PubMed     Abstract available
    
    
    
80. DHAWAN M, Priyanka, Choudhary OP
    Emergence of monkeypox: Risk assessment and containment measures.
    Travel Med Infect Dis. 2022;49:102392.
    PubMed    
    
    
    
81. ALARCON-BRAGA EA, Hernandez-Bustamante EA, Salazar-Valdivia FE, Valdez-Cornejo VA, et al
    Acceptance towards Covid-19 vaccination in Latin America and the Caribbean: A systematic review and meta-analysis.
    Travel Med Infect Dis. 2022 Jun 6:102369. doi: 10.1016/j.tmaid.2022.102369.
    PubMed     Abstract available
    
    
    May 2022
82. WEI J, Kang J, Li Z, Ou J, et al
    COVID-19 and Plasmodium falciparum co-infection in a man returning from Cameroon.
    Travel Med Infect Dis. 2022 May 30:102366. doi: 10.1016/j.tmaid.2022.102366.
    PubMed    
    
    
    
83. OLAIZ-FERNANDEZ G, Vicuna de Anda FJ, Diaz-Ramirez JB, Fajardo Dolci GE, et al
    Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 2022.
    Travel Med Infect Dis. 2022 May 28:102361. doi: 10.1016/j.tmaid.2022.102361.
    PubMed     Abstract available
    
    
    
84. LEON-FIGUEROA DA, Bonilla-Aldana DK, Pachar M, Romani L, et al
    The never ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond.
    Travel Med Infect Dis. 2022 May 25:102362. doi: 10.1016/j.tmaid.2022.102362.
    PubMed    
    
    
    
85. KC S, Faradiba D, Sittimart M, Isaranuwatchai W, et al
    Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia.
    Travel Med Infect Dis. 2022 May 17:102358. doi: 10.1016/j.tmaid.2022.102358.
    PubMed    
    
    
    
86. QUINCHO-LOPEZ A, Chavez-Rimache L, Montes-Alvis J, Taype-Rondan A, et al
    Characteristics and conflicting recommendations of clinical practice guidelines for COVID-19 management in children: A scoping review.
    Travel Med Infect Dis. 2022 May 7:102354. doi: 10.1016/j.tmaid.2022.102354.
    PubMed     Abstract available
    
    
    
87. NDEH NT, Tesfaldet YT, Budnard J, Chuaicharoen P, et al
    The secondary outcome of public health measures amidst the COVID-19 pandemic in the spread of other respiratory infectious diseases in Thailand.
    Travel Med Infect Dis. 2022;48:102348.
    PubMed     Abstract available
    
    
    April 2022
88. KOW CS, Ramachandram DS, Hasan SS
    Can COVID-19 vaccines improve cardiovascular outcomes?
    Travel Med Infect Dis. 2022 Apr 29:102350. doi: 10.1016/j.tmaid.2022.102350.
    PubMed     Abstract available
    
    
    
89. CHOUDHARY OP, A Saied A, Priyanka, Ali RK, et al
    Russo-Ukrainian war: An unexpected event during the COVID-19 pandemic.
    Travel Med Infect Dis. 2022 Apr 26:102346. doi: 10.1016/j.tmaid.2022.102346.
    PubMed    
    
    
    
90. DAS S, Samanta S, Banerjee J, Pal A, et al
    Is Omicron the end of pandemic or start of a new innings?
    Travel Med Infect Dis. 2022;48:102332.
    PubMed     Abstract available
    
    
    
91. HAMMAD NM, Saeed MA, Shaltout SW, Nofal HA, et al
    RT- PCR testing of upper respiratory tract samples for diagnosis of SARS-CoV-2: Between justification and overestimation, a multi-center international study.
    Travel Med Infect Dis. 2022;48:102334.
    PubMed     Abstract available
    
    
    
92. JASPE RC, Sulbaran Y, Loureiro CL, Moros ZC, et al
    Detection of the Omicron variant of SARS-CoV-2 in international travelers returning to Venezuela.
    Travel Med Infect Dis. 2022;48:102326.
    PubMed     Abstract available
    
    
    
93. DAL-RE R, Banzi R, Becker SL, Launay O, et al
    High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries.
    Travel Med Infect Dis. 2022;48:102321.
    PubMed     Abstract available
    
    
    March 2022
94. OMAR K, Baha Raja D, Abdul Taib NA, Rajaram N, et al
    Risk stratification and assessment framework for international travel and border measures Amidst the COVID-19 pandemic - A Malaysian perspective.
    Travel Med Infect Dis. 2022;47:102318.
    PubMed     Abstract available
    
    
    
95. WANG CT, Xu JC, Fu SC, Chao CYH, et al
    Airborne infection risk of nearby passengers in a cabin environment and implications for infection control.
    Travel Med Infect Dis. 2022;47:102285.
    PubMed     Abstract available
    
    
    
96. TUTAL E, Ozaras R, Leblebicioglu H
    Systematic review of COVID-19 and autoimmune thyroiditis.
    Travel Med Infect Dis. 2022;47:102314.
    PubMed     Abstract available
    
    
    
97. EBONGUE MSN, Lemogoum D, Endale-Mangamba LM, Barche B, et al
    Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon.
    Travel Med Infect Dis. 2022;47:102292.
    PubMed     Abstract available
    
    
    
98. NAMILAE S, Wu Y, Mubayi A, Srinivasan A, et al
    Identifying mitigation strategies for COVID-19 superspreading on flights using models that account for passenger movement.
    Travel Med Infect Dis. 2022;47:102313.
    PubMed     Abstract available
    
    
    
99. TU H, Feng J, Yu C, Lin K, et al
    Asymptomatic malaria infection at the China-Vietnam border: Knowledge and implications for the cross-border migrant population during the COVID-19 pandemic.
    Travel Med Infect Dis. 2022 Mar 8:102307. doi: 10.1016/j.tmaid.2022.102307.
    PubMed     Abstract available
    
    
    
100. KAYA T, Dilek A, Ozaras R, Balcik OS, et al
     COVID 19 and febrile neutropenia: Case report and systematic review.
     Travel Med Infect Dis. 2022 Mar 7:102305. doi: 10.1016/j.tmaid.2022.102305.
     PubMed     Abstract available
     
     
     
101. KAZYBAY B, Ahmad A, Xie Y
     Urgency of COVID-19 vaccination in adolescents: Androgen and estrogen receptors view.
     Travel Med Infect Dis. 2022 Mar 5:102306. doi: 10.1016/j.tmaid.2022.102306.
     PubMed    
     
     
     
102. GARG R, Gautam P, Suroliya V, Agarwal R, et al
     Evidence of early community transmission of Omicron (B1.1.529) in Delhi- A city with very high seropositivity and past-exposure.
     Travel Med Infect Dis. 2022;46:102276.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.